Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$58.14
0.180.31%
At close: -
$58.14
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Halozyme Therapeutics Stock Price, Quotes and Forecasts
HALONASDAQ
Halozyme Therapeutics (HALO) Forecast
NewsEarningsHalozyme Therapeutics (HALO) OptionsGuidanceDividendsAnalyst RatingsInsider TradesGovernment TradesShort InterestEdge Rankings
Stock Score Locked: Edge Members Only
Benzinga Rankings give you vital metrics on any stock – anytime.
Halozyme Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:HALO | Benzinga
Explore Halozyme Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for HALO.
Compare
EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS better than industry
FAQ
How do I buy Halozyme Therapeutics (HALO) stock?
You can purchase shares of Halozyme Therapeutics (NASDAQ:HALO) through any online brokerage.
Who are Halozyme Therapeutics (HALO) competitors?
Other companies in Halozyme Therapeutics’s space includes: Legend Biotech (NASDAQ:LEGN), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Ionis Pharmaceuticals (NASDAQ:IONS).
What is the forecast, or price target, for Halozyme Therapeutics (HALO) stock?
Halozyme Therapeutics has a consensus price target of $59.58.
What is the current price for Halozyme Therapeutics (HALO)?
The stock price for Halozyme Therapeutics (NASDAQ: HALO) is $58.14 last updated March 4, 2025 at 4:00 PM EST.
Does Halozyme Therapeutics (HALO) pay a dividend?
There are no upcoming dividends for Halozyme Therapeutics.
When is Halozyme Therapeutics (NASDAQ:HALO) reporting earnings?
Halozyme Therapeutics’s Q1 earnings are confirmed for Tuesday, May 6, 2025.
Is Halozyme Therapeutics (HALO) going to split?
There is no upcoming split for Halozyme Therapeutics.
What sector and industry does Halozyme Therapeutics (HALO) operate in?
Halozyme Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.